Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(33%)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_1
2
33%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Terminated(2)

Detailed Status

Not yet recruiting2
Recruiting2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (40.0%)
N/A3 (60.0%)

Trials by Status

terminated117%
not_yet_recruiting233%
withdrawn117%
recruiting233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DEVICE
Total Trials
6